Spinocerebellar ataxia 27B (SCA27B) is a recently described cause of autosomal dominant cerebellar ataxia caused by a (GAA)•(TTC) repeat expansion in intron 1 of the fibroblast growth factor 14 (FGF14) gene. ^{Reference Pellerin, Danzi and Wilke1} The disease is clinically characterised by an adult-onset, slowly progressive pancerebellar syndrome that is frequently associated with: episodic symptoms; visual disturbances, such as diplopia; and cerebellar oculomotor signs. ^{Reference Wilke, Pellerin and Mengel2,Reference Pellerin, Heindl and Wilke3} It is a common cause of previously unsolved late-onset cerebellar ataxia, with a frequency ranging from 10% to 61% in various ethnically diverse cohorts. ^{Reference Pellerin, Danzi and Wilke1,Reference Wilke, Pellerin and Mengel2,Reference Ashton, Indelicato and Pellerin4}

Visual disturbances and cerebellar oculomotor signs are common in spinocerebellar ataxia (SCA). ^{Reference Peng, Tu, Han, Wan and Gao5} Oculomotor disorders also appear to be common in SCA27B, with a prevalence as high as 95% in some series. ^{Reference Wilke, Pellerin and Mengel2,Reference Pellerin, Heindl and Wilke3,Reference Clément, Puisieux, Pellerin, Brais, Bonnet and Renaud6,Reference Lopergolo7}

Here, we describe the oculomotor abnormalities detected on neurological examination of five patients with SCA27B after a standardised, recorded examination. The video of the oculomotor examination was independently reviewed by two neurologists with expertise in movement disorders. The study was filed and accepted on the clinicaltrial.gov platform with the trial registration number NCT05884086 (30/05/2023).

Four French patients, aged 79, 86, 61 and 78 years, and one French-Canadian patient, aged 61 years, were included in this series (Table S1). The age of onset of the disease ranged between 40 and 76 years, with a median duration of 10 years at the time of examination. All had an autosomal dominant family history of cerebellar ataxia. The median size of the GAA repeat expansion was 485 (range, 334–550). Four patients displayed progressive cerebellar ataxia, while one patient still only exhibited episodic ataxia (patient 3). The total score on the Scale for the Assessment and Rating of Ataxia for the four patients with progressive cerebellar ataxia ranged from 4.5/40 to 23/40. In three patients, cerebellar symptoms worsened with alcohol intake and exercise; symptoms worsened with alcohol in one patient and with exercise alone in one patient.

The visual symptoms reported by the patients were mainly episodic diplopia (4/5), episodic visual blurring (3/5) and oscillopsia (3/5). Table S2 describes all the oculomotor anomalies found in the five patients. Cerebellar oculomotor anomalies on interictal clinical examination comprised abnormalities in eye pursuit. It was slow in all five patients and saccadic in four patients. When examining oculomotor saccades, only one patient had no saccade abnormalities. Two patients had isolated hypometric vertical saccades, and two had more severe saccade impairments with increased latencies, slow velocity and hypometria and, for one patient, a curved trajectory during vertical saccades with jerky oscillations at the end of the upward movement. Nystagmus was present in all patients. Two patients presented with downbeat nystagmus (DBN) and horizontal gaze-evoked nystagmus (GEN) (Video S1). Two patients had a combination of upbeat nystagmus, rebound nystagmus and horizontal-rotatory GEN. The score on the Scale for Ocular Motor Deficits in Ataxia for the 5 patients ranged from 4 to 9 out of 26, with the majority of scores for “jerk nystagmus” and “saccades” (Table S3). Oculomotor abnormalities were recorded in patient 3 during an attack of paroxysmal ataxia. The ocular pursuit was slow and saccadic. The patient displayed horizontal-rotatory nystagmus on lateral gaze, upbeat nystagmus on upward gaze and rebound nystagmus. Horizontal saccades were slow but not dysmetric, whereas vertical saccades were hypometric. Primary fixation was interrupted by saccadic intrusions.

The clinical oculomotor examination of patient 3, who was close to an episode, revealed abnormalities. At a distance from any episode, we were able to re-examine this patient, who no longer showed any visible manifestations. A vestibulonystagmography (VNG) examination could be carried out during this second evaluation, at a distance from an episode of ataxia.

Examination with VNG goggles showed flutter in all four gaze directions. Flutter can be visualized in both the vertical saccade test (Figure 1A) and the vertical pursuit test (Figure 1B). On the rotary chair test, there was a clear reduction in the vestibulo-ocular reflex gain in both clockwise and anticlockwise direction of the rotation.

Figure 1.

Graphic illustration of patient 3’s vestibulonystagmography between episodes. (A) Visulization of ocular flutter on vertical saccade examination. (B) Visualization of flutter during vertical ocular pursuit test.

Visual and cerebellar oculomotor abnormalities are among the most frequent manifestations of SCAs, with an estimated prevalence of 90% in SCA27B. ^{Reference Wilke, Pellerin and Mengel2} Our results support the previous findings from Pellerin et al., who highlighted a strong association between SCA27B and DBN and showed that SCA27B was a frequent genetic cause of DBN syndromes, accounting for almost 50% of previously idiopathic cases. ^{Reference Pellerin, Heindl and Wilke3}

Oculomotor assessment is important in SCA27B as it may show many possible oculomotor abnormalities beyond DBN. These may be present as early as the episodic stage, guiding the clinician towards this diagnosis. A complete oculomotor examination is therefore recommended in clinical practice to guide the molecular analysis of SCA27B. In fact, this ataxia seems to be very common among cerebellar ataxias. ^{Reference Pellerin, Danzi and Wilke1,Reference Clément, Puisieux, Pellerin, Brais, Bonnet and Renaud6,Reference Méreaux, Davoine and Pellerin8} Although the diagnosis of certainty obviously remains genetic, signs particularly favourable to the diagnosis will guide the genetic prescription.

It is likely that these various disorders reflect early damage to the cerebellum, particularly the cerebellar flocculus and paraflocculus, in the course of SCA27B. ^{Reference Pellerin, Heindl and Wilke3}

Cerebellar oculomotor disorders are common among cerebellar ataxia. Among other episodic ataxias, type 1 episodic ataxia (EA1) is linked to a pathogenic variant in the KCNA1 gene and type 2 episodic ataxia (EA2) to a pathogenic variant in CACNA1A. Both ataxias begin in childhood and are characterised by episodes of ataxia. DBN is described in EA2 as in SCA27B, but oculomotor disturbances are usually absent in EA1. ^{Reference Jen, Kim and Baloh9,Reference Graves, Griggs and Bundy10}

About SCAs, impaired pursuit and saccadic dysmetria are observed in many SCAs (SCA 1, 2, 3, 6, 7 and 17) and may precede the first symptoms of ataxia. ^{Reference Peng, Tu, Han, Wan and Gao5} Sixty percent of patients with SCAs have nystagmus. Gaze-evoked nystagmus is the most commonly observed. In our cohort, gaze-evoked nystagmus was even more frequent and was found in all our patients. DBN was found in only two out of five patients (40%), a lower frequency than in the cohort of Méreaux et al., which found DBN in 63.6% of their patients. ^{Reference Méreaux, Davoine and Pellerin8}

There are a number of therapeutic avenues for cerebellar ataxia, some of which are currently the subject of more in-depth research. According to Ashton et al., a partial improvement was observed in the symptoms of SCA27B patients treated with acetazolamide. ^{Reference Ashton, Indelicato and Pellerin4} Another treatment considered in SCA27B is 4-aminopyridine, which reduced the frequency and/or severity of ataxic symptoms in a previous small series of patients with SCA27B. ^{Reference Wilke, Pellerin and Mengel2} Placebo-controlled video-oculography data of four FGF14 patients previously enrolled in a 4-AP randomised double-blind trial showed a significant decrease in slow phase velocity of DBN with 4-AP, but not placebo. ^{Reference Pellerin, Heindl and Wilke3}

Visual symptoms and cerebellar oculomotor abnormalities are some of the key features of SCA27B. Proper assessment and treatment are major challenges in the management of SCA27B patients. Given the numerous oculomotor abnormalities found in SCA27B, further studies by videonystagmography should be performed to document these findings more precisely and on a larger scale.